Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post‐hoc analysis of SHIFT

@article{Komajda2016ChronicET,
  title={Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post‐hoc analysis of SHIFT},
  author={Michel Komajda and Luigi T Tavazzi and Karl Swedberg and Michael B{\"o}hm and Jeffrey S. Borer and Aur{\'e}lie Moyne and Ian Ford Ford},
  journal={European journal of heart failure},
  year={2016},
  volume={18 9},
  pages={
          1182-9
        }
}
AIMS During the post-discharge phase following a heart failure hospitalization (HFH), patients are at high risk of early readmission despite standard of care therapy. We examined the impact of chronic exposure to ivabradine on early readmissions in patients hospitalized for heart failure during the course of the SHIFT study (Systolic Heart Failure treatment with the If inhibitor ivabradine Trial). METHODS AND RESULTS A total of 1186 of the 6505 randomized patients experienced at least one HFH… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations